EPISODE · Jul 5, 2023 · 26 MIN
Review of MDMA and LSD, intro to psilocybin
from Neural Pharm Podcast · host Dr. Colby Burns, PharmD and Dr. Christopher Toney, PharmD
References:Gotvaldova K, et al. "Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids". International Journal of Molecular Sciences. 2023 (22): 14068.Halpern J, Roth BL "Hallucinogens and dissociative agents naturally growing in the United States". Pharmacology & Therapeutics. 2004; 102 (2): 131–8.Huberman A. The science of MDMA and its therapeutic uses: benefits and risks. Huberman Labs (podcast). 12 Jun 2023Pollan M. How to change your mind: the new science of psychedelics. Penguin Press. 2019Sumner R, et al. Microdosed LSD: Dose day outcomes from a home-administered randomized controlled trial. 2023. Unpublished (information from poster presentation at MAPS conference)Woolley DW, Campbell NK (1962). "Serotonin-like and antiserotonin properties of psilocybin and psilocin". Science. 3518. 136 (3518): 777–8Vizeli P, et al. Genetic influence of Cyp2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis. Scientific Reports. 2021(11); 10851. Get full access to Neural Pharm at neuralpharm.substack.com/subscribe
NOW PLAYING
Review of MDMA and LSD, intro to psilocybin
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m